Gyre Therapeutics
GYRE
GYRE
16 hedge funds and large institutions have $15.6M invested in Gyre Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
48% less funds holding
Funds holding: 31 → 16 (-15)
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
Holders
16
Holding in Top 10
–
Calls
$2.23M
Puts
$514K
Top Buyers
| 1 | +$4.73M | |
| 2 | +$4.42M | |
| 3 | +$3.01M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$484K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$436K |
Top Sellers
| 1 | -$573K | |
| 2 | -$47.1K | |
| 3 | -$43.4K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$32.7K |
| 5 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
-$32.3K |